Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
TERMINATED
NCT00350844
PHASE1/PHASE2

Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

View on ClinicalTrials.gov

Summary

The goal of this study is to test the hypothesis that hydroxyurea is effective for the specific treatment of secondary pulmonary hypertension found on screening in children and young adults with sickle cell disease.

Official title: A Pilot Study of Hydroxyurea for the Treatment of Pulmonary Hypertension in Children and Young Adults With Sickle Cell Disease

Key Details

Gender

All

Age Range

10 Years - 25 Years

Study Type

INTERVENTIONAL

Enrollment

6

Start Date

2006-07

Completion Date

2008-06

Last Updated

2026-09-24

Healthy Volunteers

No

Interventions

DRUG

Hydroxyurea

Drug to be initiated at standard starting dose with dose escalation until maximum tolerated dose reached.

Locations (1)

Ann & Robert H Lurie Children's Hospital of Chicago

Chicago, Illinois, United States